Genticel SA (GTCL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Genticel SA (Genticel), formerly BT Pharma, is a biopharmaceutical company that develops therapeutic vaccines for women infected by the human papillomavirus. The company provides pipeline products including ProCervix, a bivalent HPV therapeutic vaccine candidate and multivalent candidate vaccines for patients infected with HPV. It offers technologies such as CyaA vector platform and Vaxiclase for developing products. Genticel also provides clinical trials services. The companys ProCervix is used for women infected with HPV 16 or HPV 18, before high grade lesions or cervical cancer occur. It operates in Paris and Labege. Genticel is headquartered in Labege, France.
Genticel SA (GTCL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Genticel SA (Genticel), formerly BT Pharma, is a biopharmaceutical company that develops therapeutic vaccines for women infected by the human papillomavirus. The company provides pipeline products including ProCervix, a bivalent HPV therapeutic vaccine candidate and multivalent candidate vaccines for patients infected with HPV. It offers technologies such as CyaA vector platform and Vaxiclase for developing products. Genticel also provides clinical trials services. The companys ProCervix is used for women infected with HPV 16 or HPV 18, before high grade lesions or cervical cancer occur. It operates in Paris and Labege. Genticel is headquartered in Labege, France.
Genticel SA (GTCL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genticel SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genticel SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genticel SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genticel SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Genticel SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Genticel SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Genticel Raises US$23.7 Million In Series C Financing 10
Partnerships 12
Genticel Enters into Agreement with Roche Molecular Systems 12
Merger 13
Genticel Merges with GenKyoTex 13
Licensing Agreements 15
Genticel Enters into Licensing Agreement with Serum Institute of India 15
Equity Offering 16
Genticel Completes IPO For USD47.7 Million 16
Genticel SA - Key Competitors 17
Genticel SA - Key Employees 18
Genticel SA - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Jan 30, 2017: Genticel Business Update-Fourth Quarter 2016 20
Oct 27, 2016: Genticel: Business Update - Third Quarter 2016 22
Sep 22, 2016: Genticel Presents First Half 2016 Financial Results And Updates Its Operational Outlook 23
Jul 28, 2016: Genticel: Business Update - Second Quarter 2016 26
Mar 14, 2016: Genticel Announces 2015 Annual Results and Strategic Update for 2016 27
Jan 25, 2016: Business Update Fourth Quarter 2015 30
Corporate Communications 32
Jan 05, 2016: Genticel Appoints Remi Palmantier, PhD, as Chief Scientific Officer to Accelerate Its Development 32
Other Significant Developments 33
Apr 28, 2016: Genticel Provides Business Update First Quarter 2016 33
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
Genticel SA, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Genticel SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genticel SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genticel SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genticel SA, Deals By Therapy Area, 2011 to YTD 2017 8
Genticel SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Genticel Raises US$23.7 Million In Series C Financing 10
Genticel Enters into Agreement with Roche Molecular Systems 12
Genticel Merges with GenKyoTex 13
Genticel Enters into Licensing Agreement with Serum Institute of India 15
Genticel Completes IPO For USD47.7 Million 16
Genticel SA, Key Competitors 17
Genticel SA, Key Employees 18
Genticel SA, Other Locations 19
Table of Contents 3
List of Tables 4
List of Figures 4
Genticel SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genticel SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genticel SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genticel SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Genticel SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Genticel SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Genticel Raises US$23.7 Million In Series C Financing 10
Partnerships 12
Genticel Enters into Agreement with Roche Molecular Systems 12
Merger 13
Genticel Merges with GenKyoTex 13
Licensing Agreements 15
Genticel Enters into Licensing Agreement with Serum Institute of India 15
Equity Offering 16
Genticel Completes IPO For USD47.7 Million 16
Genticel SA - Key Competitors 17
Genticel SA - Key Employees 18
Genticel SA - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Jan 30, 2017: Genticel Business Update-Fourth Quarter 2016 20
Oct 27, 2016: Genticel: Business Update - Third Quarter 2016 22
Sep 22, 2016: Genticel Presents First Half 2016 Financial Results And Updates Its Operational Outlook 23
Jul 28, 2016: Genticel: Business Update - Second Quarter 2016 26
Mar 14, 2016: Genticel Announces 2015 Annual Results and Strategic Update for 2016 27
Jan 25, 2016: Business Update Fourth Quarter 2015 30
Corporate Communications 32
Jan 05, 2016: Genticel Appoints Remi Palmantier, PhD, as Chief Scientific Officer to Accelerate Its Development 32
Other Significant Developments 33
Apr 28, 2016: Genticel Provides Business Update First Quarter 2016 33
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List Of Tables
List of TablesGenticel SA, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Genticel SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genticel SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genticel SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genticel SA, Deals By Therapy Area, 2011 to YTD 2017 8
Genticel SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Genticel Raises US$23.7 Million In Series C Financing 10
Genticel Enters into Agreement with Roche Molecular Systems 12
Genticel Merges with GenKyoTex 13
Genticel Enters into Licensing Agreement with Serum Institute of India 15
Genticel Completes IPO For USD47.7 Million 16
Genticel SA, Key Competitors 17
Genticel SA, Key Employees 18
Genticel SA, Other Locations 19
RELATED REPORTS
SAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
